TGF-beta: a master immune regulator-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TGF-beta: a master immune regulator

Published:2020-04-12 Issue:5 Volume:24 Page:427-438
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Larson Christopher¹,Oronsky Bryan¹,Carter Corey A.¹,Oronsky Arnold¹²,Knox Susan J.³,Sher David⁴,Reid Tony R.⁵

Affiliation:

1. EpicentRx, San Diego, CA, USA

2. InterWest Partners, Menlo Park, CA, USA

3. Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA

4. Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, TX, USA

5. Department of Medical Oncology, UC San Diego School of Medicine, La Jolla, CA, USA

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2020.1744568

Reference125 articles.

1. Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium.

2.

Blocking TGF-β Signaling To Enhance The Efficacy Of Immune Checkpoint Inhibitor

3. One checkpoint may hide another: inhibiting the TGFβ signaling pathway enhances immune checkpoint blockade

4. Transforming growth factor-β: A therapeutic target for cancer

5. Costs of cardiovascular disease prevention care and scenarios for cost saving

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LAMTOR1/mTORC1 promotes CD276 to induce immunosuppression via PI3K/Akt/MMP signaling pathway in Clostridium perfringens–induced necrotic enteritis of laying hens;Poultry Science;2024-12

2. Overexpression of microRNA-611 inhibits TGF-β-induced epithelial-mesenchymal transition and migration in lung cancer cells through MAPKAP1;Cellular Signalling;2024-11

3. Combination of Youhua Kuijie Prescription and sulfasalazine can alleviate experimental colitis via IL-6/JAK2/STAT3 pathway;Frontiers in Pharmacology;2024-09-10

4. Expanding horizons in cancer therapy by immunoconjugates targeting tumor microenvironments;Critical Reviews in Oncology/Hematology;2024-09

5. Salivary Interleukin-13 and Transforming Growth Factor Beta as Potential Biomarkers of Cancer Cachexia;Cancers;2024-08-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3